{"schema_version":"1","generated_at":"2026-10-31T08:54:26.788Z","data_as_of":null,"url":"https://www.findmykol.com/kol/byram-ozer","json_url":"https://www.findmykol.com/kol/byram-ozer/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"byram-ozer","name":"Byram Ozer","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Atlanta","state":"GA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1326335985","orcid":"0009-0009-5644-2733","openalex":"A5061557159"},"summary":"Byram Ozer is an Oncology physician. OpenAlex indexes 70 publications with 415 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":70,"cited_by_count":415,"h_index":10,"latest_activity_year":2026,"source":"works"},"prescribing":{"data_year":2021,"areas_total":3,"areas_shown":3,"areas":[{"area":"Sensory organs","share_pct":47.5,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":47.5,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":32.2,"classes_total":1,"classes":[{"class":"Other antiepileptics","setting":"prescribed","share_pct":32.2,"drugs":[{"name":"Levetiracetam","share_pct":100}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":20.3,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":20.3,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2021,"office_pct":26,"facility_pct":74},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas","year":2026,"journal":"Neuro-Oncology Advances","source_url":"https://doi.org/10.1093/noajnl/vdag016","status":"verified"},{"title":"Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumors","year":2025,"journal":"Neuro-Oncology Advances","source_url":"https://doi.org/10.1093/noajnl/vdaf089","status":"verified"},{"title":"Liposomal curcumin and standard radiation and temozolomide for newly diagnosed high-grade gliomas: A phase 1/2 study.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.tps2095","status":"verified"},{"title":"Glioblastoma-enriched glycosphingolipids modulate the function of human iNKT cells","year":2025,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noaf135","status":"verified"},{"title":"Phase I/II and window-of-opportunity study of pamiparib and metronomic temozolomide for recurrent isocitrate dehydrogenase mutant gliomas","year":2025,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noaf246","status":"verified"}],"source":"works"},"contact":{"address_1":"1365 CLIFTON RD NE BLDG C","city":"Atlanta","state":"GA","zip":"303221013","phone":"404-778-1900","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1326335985","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2026-02-06","provider_certified":"2026-02-06","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2021}},"methodology_url":"https://www.findmykol.com/about#methodology"}